Bridging today’s limitations with tomorrow’s breakthroughs—one clinical trial at a time. | Regeneron
FacebookRegeneron
Bridging today’s limitations with tomorrow’s breakthroughs—one clinical trial at a time. | Regeneron
Regeneron. . Bridging today’s limitations with tomorrow’s breakthroughs—one clinical trial at a time.
1.3K views1 month ago
Regeneron Stock Analysis
Driven by Discovery
0:59
Driven by Discovery
YouTubeSTAT Brand Studio
1 views17 hours ago
Tech Trailblazers Ep. 1 | Exploring Immune Responses in Gene Therapy Delivery with Andrew Baik
0:41
Tech Trailblazers Ep. 1 | Exploring Immune Responses in Gene Therapy Delivery with Andrew Baik
YouTubeRegeneron
248 views1 month ago
Tech Trailblazers Ep. 1 | Exploring Immune Responses in Gene Therapy Delivery with Andrew Baik
0:38
Tech Trailblazers Ep. 1 | Exploring Immune Responses in Gene Therapy Delivery with Andrew Baik
YouTubeRegeneron
170 views1 month ago
Top videos
6.6K views | For clinical investigators, every clinical trial is a chance to contribute to progress for their patients. | Regeneron | Facebook
6.6K views | For clinical investigators, every clinical trial is a chance to contribute to progress for their patients. | Regeneron | Facebook
FacebookRegeneron
2K views1 week ago
For clinical investigators, every clinical trial is a chance to contribute to progress for their patients. | Regeneron
For clinical investigators, every clinical trial is a chance to contribute to progress for their patients. | Regeneron
FacebookRegeneron
8.2K views1 month ago
We’re excited to share that the U.S. FDA has approved our medicine as an adjuvant treatment for people with cutaneous squamous cell carcinoma (#CSCC) with high risk of recurrence after surgery and radiation. We believe the CSCC community deserves more from their care, and we remain committed to further advancing research that addresses unmet needs and makes a meaningful difference for people living with high-risk CSCC. Learn more: https://bit.ly/42zjjX3 | Regeneron
We’re excited to share that the U.S. FDA has approved our medicine as an adjuvant treatment for people with cutaneous squamous cell carcinoma (#CSCC) with high risk of recurrence after surgery and radiation. We believe the CSCC community deserves more from their care, and we remain committed to further advancing research that addresses unmet needs and makes a meaningful difference for people living with high-risk CSCC. Learn more: https://bit.ly/42zjjX3 | Regeneron
FacebookRegeneron
483 views1 month ago
Regeneron Science Talent Search
Tech Trailblazers Ep. 1 | Exploring Immune Responses in Gene Therapy Delivery with Andrew Baik
0:48
Tech Trailblazers Ep. 1 | Exploring Immune Responses in Gene Therapy Delivery with Andrew Baik
YouTubeRegeneron
132 views1 month ago
Tech Trailblazers Ep. 2 | REGENIE in Action with Joelle Mbatchou
0:46
Tech Trailblazers Ep. 2 | REGENIE in Action with Joelle Mbatchou
YouTubeRegeneron
64 views1 month ago
How Regeneron Scientists Study Disease Up Close
0:32
How Regeneron Scientists Study Disease Up Close
YouTubeRegeneron
43 views1 month ago
6.6K views | For clinical investigators, every clinical trial is a chance to contribute to progress for their patients. | Regeneron | Facebook
6.6K views | For clinical investigators, every clinical trial i…
2K views1 week ago
FacebookRegeneron
For clinical investigators, every clinical trial is a chance to contribute to progress for their patients. | Regeneron
For clinical investigators, every clinical trial is a chance to contrib…
8.2K views1 month ago
FacebookRegeneron
We’re excited to share that the U.S. FDA has approved our medicine as an adjuvant treatment for people with cutaneous squamous cell carcinoma (#CSCC) with high risk of recurrence after surgery and radiation. We believe the CSCC community deserves more from their care, and we remain committed to further advancing research that addresses unmet needs and makes a meaningful difference for people living with high-risk CSCC. Learn more: https://bit.ly/42zjjX3 | Regeneron
We’re excited to share that the U.S. FDA has approved our medicine a…
483 views1 month ago
FacebookRegeneron
Regeneron aims for COVID-19 drug trials by early summer
3:05
Regeneron aims for COVID-19 drug trials by early summer
Mar 17, 2020
CNBC
59K views · 592 reactions | JUST IN: Regeneron now aims to have doses of a potential COVID-19 drug ready to start human testing by early summer. https://cnb.cx/2vrWN66 | CNBC | Facebook
3:06
59K views · 592 reactions | JUST IN: Regeneron now aims to have dose…
59.5K views2 weeks ago
FacebookCNBC
Regeneron Antibody Research & Medicines
Regeneron Antibody Research & Medicines
11 months ago
regeneron.com
4.8K views · 115 reactions |  Yesterday we announced our plans to...
0:43
4.8K views · 115 reactions |  Yesterday we announced our plan…
2K views2 weeks ago
FacebookRegeneron
0:56
1.2K views · 66 reactions | We asked a few of our #scientists what moti…
2K views4 weeks ago
FacebookRegeneron
What is Regeneron: 5 things to know about the Westchester-base…
Oct 7, 2020
lohud.com
0:44
2.3K views · 87 reactions | Alina Baum, PhD, Senior Staff Scientist...
2.4K views3 weeks ago
FacebookRegeneron
1:03
Roche, Regeneron link up on antibodies
11.1K viewsAug 19, 2020
YahooReuters Videos
0:54
19 reactions | Thanks for following along during the American Colleg…
2K views4 weeks ago
FacebookRegeneron
0:06
We're bringing more to the fight against serious diseases. Regener…
82.3K views1 month ago
FacebookRegeneron
We're bringing more to the fight against serious diseases. Regener…
51.5K views6 months ago
FacebookRegeneron
What drives a clinical trial investigator? The chance to supp…
16.9K views1 month ago
FacebookRegeneron
0:31
Through clinical trials, we can answer more questions, develop …
124.7K views11 months ago
FacebookRegeneron
1:49
1.9K views · 96 reactions | Hear from our EVP of Research, Drew...
2K views1 week ago
FacebookRegeneron
0:22
1.2K views · 69 reactions | Our Automated Biobanking Core grou…
2K views2 weeks ago
FacebookRegeneron
1:26
Talk to your doctor to see if a clinical trial is right for you. | Rege…
222.1K views7 months ago
FacebookRegeneron
0:31
972 views | Reel by Regeneron
2K views3 weeks ago
FacebookRegeneron
0:16
11K views · 230 reactions | Discover. Develop. Deliver. Repeat. It’s the r…
883.9K views2 weeks ago
FacebookRegeneron
0:08
You are part of the future of healthcare. Learn how your involv…
275.6K views5 months ago
FacebookRegeneron
0:07
20 reactions | Having trouble completing everyday tasks due to …
2K views3 weeks ago
FacebookRegeneron
0:11
Our knowledge of the body is ever-changing. Learning about the role …
298.7K viewsOct 23, 2020
FacebookRegeneron
0:36
25K views | Reel by Regeneron
25.9K views3 weeks ago
FacebookRegeneron
2:37
Regeneron to acquire bankrupt genetic tester 23andMe
15.1K views5 months ago
YahooYahoo Finance Video
0:30
When it comes to corporate responsibility, we give it our every…
467.7K views6 months ago
FacebookRegeneron
0:23
4K views | The holiday season is a good time to check in with loved o…
4.1K views5 days ago
FacebookRegeneron
1:59
151 reactions · 39 shares | Our President and Chief Scientist, Geo…
793.8K views2 weeks ago
FacebookRegeneron
See more videos
Static thumbnail place holder